Faulty breast implants-400 Swedish women win compensation
France: A French court on Thursday ordered the German safety certifier that approved defective breast implants for use to compensate around 400 Swedish women who received the devices behind a global health scare.
The court in the Paris suburb of Nanterre ordered TUV to pay 4,600 euros ($5,200) to each of the Swedish plaintiffs for the harm caused by approving implants made by French firm Poly Implant Prothese (PIP).
It also ordered the company to reimburse the cost of having the implants -- which were filled with a cheap industrial-grade silicone gel used in electronic equipment -- removed.
It comes a month after France's highest appeals court ordered that TUV is retried for negligence over its role in the affair, after being initially cleared of liability by a lower court.
After a separate trial, the company had already been ordered to pay 60 million euros ($69 million) as a deposit for potential compensation for 20,000 women who received the defective implants.
The PIP implant scandal made global headlines in 2011 after doctors first noticed abnormally high rupture rates in the implants.
Some 400,000 worldwide, mostly in Latin America, are believed to have received the enhancements.
Thousands had them removed, despite health authorities in several countries declaring them not to be toxic.
PIP's founder, Jean-Claude Mas, was convicted of fraud and sentenced to four years in jail. His company was shut down in 2010.
Also Read: Faulty Implant: J&J launches IPAP Reimbursement Programme
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd